StockData

Yarrow Bioscience, Inc. (YARW) stock

YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30105% above fair value
$14.35+0.14 (+0.99%)

Close on Nov 18, 2026Market cap $38.31MP/E –Yield –

Yarrow Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Yarrow Bioscience's revenue for the twelve months ending Jun 30, 2025 was $476.00K, down 2.1% year over year. For fiscal 2025 it was $570.00K, up 13.8% from the year before. The highest annual figure on record is $20.99M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$570.00K+13.8%
FY2024Dec 31, 2024$501.00K+18.2%
FY2023Dec 31, 2023$424.00K-11.1%
FY2022Dec 31, 2022$477.00K-48.8%
FY2021Dec 31, 2021$931.00K-95.6%
FY2020Dec 31, 2020$20.99M+4638.8%
FY2019Dec 31, 2019$443.00K-87.7%
FY2018Dec 31, 2018$3.60M-21.5%
FY2017Dec 31, 2017$4.58M+579.8%
FY2016Dec 31, 2016$674.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$97.00K+15.5%
Q1 FY2026Mar 31, 2026$86.00K-28.9%
Q2 FY2025Jun 30, 2025$69.00K-65.2%
Q1 FY2025Mar 31, 2025$202.00K+106.1%
Q4 FY2024Dec 31, 2024$84.00K+10.5%
Q3 FY2024Sep 30, 2024$121.00K+6.1%
Q2 FY2024Jun 30, 2024$198.00K+46.7%
Q1 FY2024Mar 31, 2024$98.00K-1.0%
Q4 FY2023Dec 31, 2023$76.00K+1166.7%
Q3 FY2023Sep 30, 2023$114.00K-31.7%
Q2 FY2023Jun 30, 2023$135.00K+7.1%
Q1 FY2023Mar 31, 2023$99.00K-44.4%
Q4 FY2022Dec 31, 2022$6.00K-97.8%
Q3 FY2022Sep 30, 2022$167.00K+25.6%
Q2 FY2022Jun 30, 2022$126.00K-57.3%
Q1 FY2022Mar 31, 2022$178.00K-22.6%
Q4 FY2021Dec 31, 2021$273.00K-93.6%
Q3 FY2021Sep 30, 2021$133.00K-95.9%
Q2 FY2021Jun 30, 2021$295.00K-97.5%
Q1 FY2021Mar 31, 2021$230.00K-86.9%
Q4 FY2020Dec 31, 2020$4.29M+3074.8%
Q3 FY2020Sep 30, 2020$3.27M–
Q2 FY2020Jun 30, 2020$11.69M–
Q1 FY2020Mar 31, 2020$1.75M+468.2%
Q4 FY2019Dec 31, 2019$135.00K–
Q3 FY2019Sep 30, 2019$0–
Q2 FY2019Jun 30, 2019$0-100.0%
Q1 FY2019Mar 31, 2019$308.00K-38.0%
Q4 FY2018Dec 31, 2018$0-100.0%
Q3 FY2018Sep 30, 2018$0-100.0%
Q2 FY2018Jun 30, 2018$10.14M+2159.0%
Q1 FY2018Mar 31, 2018$497.00K+10.7%
Q4 FY2017Dec 31, 2017$2.78M–
Q3 FY2017Sep 30, 2017$909.00K–
Q2 FY2017Jun 30, 2017$449.00K–
Q1 FY2017Mar 31, 2017$449.00K–

More Yarrow Bioscience figures

See a number that looks wrong?